Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT06632223
Active, not recruiting Not applicable

Sensory Motor Training on Foot Weight Distribution in Patients With Foot Burn

NCT06632223 · tracked via the Priya Life Science Egypt tracker
Sponsor
Shaimaa Mohamed Ahmed Elsayeh
Phase
Not applicable
Started
2024-07-01
Last updated
2024-10-09

Condition(s) studied

BurnPostural Stability

Investigational drug(s) / intervention(s)

Sensory motor trainingTraditional physical therapy

Sensory motor training: Each session will be composed of 10 minutes of warm-up, followed by 50-60 minutes of sensory motor exercises, followed by 5-10 minutes of cool down.

Traditional physical therapy: traditional physical therapy program in form of stretching exercises, strengthening exercises, scar management, and gait training

Study summary

The purpose of the current study is to investigate the effect sensory motor training on foot weight distribution and postural stability in patients with foot burn.

Eligibility

Sex
ALL
Min age
20 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Patients will suffer from foot \"planter surface\" second degree thermal burn (Partial thickness). * Patients who have undergone skin grafting and those who have not undergone skin grafting are both eligible for inclusion in the study. * Patients will begin the training program after complete wound healing. * Patients will be given their informed consent. Exclusion Criteria: * Patients who had an open wound at or near treatment site. * Patients who had chemical or electrical burn. * Patients with specific conditions such as musculoskeletal impairments impacting independent walking (e.g., strokes, severe arthritis). * Uncontrolled cardiovascular or pulmonary diseases. * Patients with neurological, psychiatric illness, severe behavior or cognitive disorders. * Metabolic or vascular disease with a neurological component such as diabetes. * Patients with hearing problems, individuals with otitis media, and patients experiencing nystagmus and visual problems. * Malignant conditions. * Uncooperative patients.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Physical Therapy, Cairo University, Egypt. Cairo Giza Governorate

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06632223 on ClinicalTrials.gov ↗ ← All trials in Egypt